Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HCFA Refers PET Review To MCAC, Citing Difference Of Opinion On Evidence

This article was originally published in The Gray Sheet

Executive Summary

The Health Care Financing Administration has assured Senator Ted Stevens (R-Alaska) that a national coverage decision will be made on positron emission tomography (PET) by Dec. 15.

You may also be interested in...



Philips Medical Taps Expanding PET Reimbursement Via ADAC Acquisition

Philips Medical Systems will leverage expanding Medicare coverage for positron emission tomography (PET) imaging procedures through the acquisition of PET device maker ADAC Laboratories under an agreement announced Nov. 13.

Philips Medical Taps Expanding PET Reimbursement Via ADAC Acquisition

Philips Medical Systems will leverage expanding Medicare coverage for positron emission tomography (PET) imaging procedures through the acquisition of PET device maker ADAC Laboratories under an agreement announced Nov. 13.

UCLA Requests Medicare Coverage Of PET Scans For All Oncology Indications

Positron emission tomography (PET) scans led to a "change in management" in 100% of 301 patients being diagnosed for breast cancer, according UCLA's analysis of published literature in a July 10 Medicare coverage request submitted to the Health Care Financing Administration.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel